Abbott Molecular, Inc. recalls In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Products that were intended for export only which were not approved or registered in accordance with U.S. specifications were shipped to U.S. customers.
- Products
-
- In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit
- Company
- Abbott Molecular, Inc.
- Where it was sold
-
US Nationwide distribution in the states of AL, CA, IL, MA, MD, MN, NY, and PA.
States: Alabama, California, Illinois, Massachusetts, Maryland, Minnesota, New York, Pennsylvania
- Barcodes
0088499903536200884999000766- Units affected
- 16 kits
- About this recall
- In-vitro diagnostic kits: (1) Abbott Vysis MDM2 / CEP 12 FISH Probe Kit, REF 01N15-010; (2) Abbott Vysis LSI D13S319 (13q14.3) SpectrumOrange Probe, REF 01N34-020;